Publication:
Infliximab as an alternative treatment for Behcet disease when other therapies fail

dc.contributor.authorsUgras, Meltem; Ertem, Deniz; Celikel, Cigdem; Pehlivanoglu, Ender
dc.date.accessioned2022-03-12T17:33:41Z
dc.date.accessioned2026-01-11T16:34:48Z
dc.date.available2022-03-12T17:33:41Z
dc.date.issued2008
dc.identifier.doi10.1097/MPG.0b013e3181346b60
dc.identifier.issn0277-2116
dc.identifier.pubmed18223383
dc.identifier.urihttps://hdl.handle.net/11424/228892
dc.identifier.wosWOS:000252620600015
dc.language.isoeng
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.relation.ispartofJOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectINFLAMMATORY-BOWEL-DISEASE
dc.subjectNECROSIS-FACTOR-ALPHA
dc.subjectCROHNS-DISEASE
dc.subjectCOLCHICINE
dc.subjectLYMPHOMA
dc.titleInfliximab as an alternative treatment for Behcet disease when other therapies fail
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage215
oaire.citation.issue2
oaire.citation.startPage212
oaire.citation.titleJOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
oaire.citation.volume46

Files